News | June 22, 2022
Sadhana Nitro Chem commences production of its 1st para aminophenol plant
The company is now introducing the product into the India pharmaceutical market.
The company is now introducing the product into the India pharmaceutical market.
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Subscribe To Our Newsletter & Stay Updated
